WASHINGTON — After 15 years at the helm of the lobbying group for pharmacy benefit managers, Mark Merritt’s parting gift was a stone blue baseball cap. “PCMA,” the group’s acronym, was embroidered in red on the front, “Merritt 15-0” in white on the back.

“15 years here and we haven’t had any significant losses,” explained Merritt, the group’s current CEO.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Of course he has “No regrets” because he knows that the criminals that helped him fleece the American taxpayers, won’t be indicted. He know he is above the Law. Our federal regulators were unable to turn down the money this guy generated for his Industry. He was incredibly effective handling how the media covered, or didn’t the billions of extra dollars these criminals added to the Medicare Part D program. Just another corporate criminal normalized by industry funded media outlets like this one.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy